Smith-Byrne, Karl http://orcid.org/0000-0002-1932-7463
Hedman, Åsa
Dimitriou, Marios http://orcid.org/0000-0001-8362-2099
Desai, Trishna
Sokolov, Alexandr V.
Schioth, Helgi B.
Koprulu, Mine http://orcid.org/0000-0001-6870-4539
Pietzner, Maik http://orcid.org/0000-0003-3437-9963
Langenberg, Claudia http://orcid.org/0000-0002-5017-7344
Atkins, Joshua http://orcid.org/0000-0003-0821-1112
Penha, Ricardo Cortez
McKay, James
Brennan, Paul
Zhou, Sirui http://orcid.org/0000-0003-4963-0815
Richards, Brent J. http://orcid.org/0000-0002-3746-9086
Yarmolinsky, James
Martin, Richard M. http://orcid.org/0000-0002-7992-7719
Borlido, Joana http://orcid.org/0000-0003-2622-0901
Mu, Xinmeng J.
Butterworth, Adam http://orcid.org/0000-0002-6915-9015
Shen, Xia http://orcid.org/0000-0003-4390-1979
Wilson, Jim
Assimes, Themistocles L. http://orcid.org/0000-0003-2349-0009
Hung, Rayjean J. http://orcid.org/0000-0002-4486-7496
Amos, Christopher http://orcid.org/0000-0002-8540-7023
Purdue, Mark
Rothman, Nathaniel
Chanock, Stephen http://orcid.org/0000-0002-2324-3393
Travis, Ruth C.
Johansson, Mattias
Mälarstig, Anders
Funding for this research was provided by:
Cancer Research UK (C8221/A29017)
Article History
Received: 12 May 2023
Accepted: 5 March 2024
First Online: 29 April 2024
Competing interests
: Å.H., M.D., J.B., X.J.M. and A.M. are employees at Pfizer Inc., the remaining authors declare no competing interests.